Plasma sphingolipids and depressive symptoms in coronary artery disease-Reference-Cited by-同舟云学术

Plasma sphingolipids and depressive symptoms in coronary artery disease

Published:2017-09-26 Issue:11 Volume:7 Page:e00836
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Dinoff Adam¹²,Saleem Mahwesh¹²,Herrmann Nathan¹³,Mielke Michelle M.⁴⁵,Oh Paul I.⁶⁷,Venkata Swarajya Lakshmi Vattem⁸,Haughey Norman J.⁸⁹,Lanctôt Krista L.¹²³⁷^ORCID

Affiliation:

1. Neuropsychopharmacology Research Group; Hurvitz Brain Sciences Program; Sunnybrook Research Institute; Toronto ON Canada

2. Department of Pharmacology and Toxicology; Faculty of Medicine; University of Toronto; Toronto ON Canada

3. Department of Psychiatry; Faculty of Medicine; University of Toronto; Toronto ON Canada

4. Department of Neurology; Mayo Clinic; Rochester MN USA

5. Department of Health Sciences Research; Mayo Clinic; Rochester MN USA

6. Division of Clinical Pharmacology; Sunnybrook Health Sciences Centre; Toronto ON Canada

7. Toronto Rehabilitation Institute Rumsey Centre Cardiac Rehabilitation; Toronto ON Canada

8. Department of Neurology; Johns Hopkins University School of Medicine; Baltimore MD USA

9. Department of Psychiatry; Johns Hopkins University School of Medicine; Baltimore MD USA

Funder

Canadian Institutes of Health Research

Alzheimer Society

Publisher

Wiley

Subject

Behavioral Neuroscience

Reference93 articles.

1. Increasing off-label use of antipsychotic medications in the United States, 1995-2008;Alexander;Pharmacoepidemiology and Drug Safety,2011

2. ‘Vascular depression’ hypothesis;Alexopoulos;Archives of General Psychiatry,1997a

3. Clinically defined vascular depression;Alexopoulos;American Journal of Psychiatry,1997b

4. Trajectories of stress, depressive symptoms, and immunity in cancer survivors: Diagnosis to 5 years;Andersen;Clinical Cancer Research,2016

5. Ceramide in apoptosis signaling: Relationship with oxidative stress;Andrieu-Abadie;Free Radical Biology and Medicine,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Comorbid Depression after Social Fear Conditioning in Mice and Its Effects on Brain Sphingolipid Metabolism;Cells;2023-05-10

2. Contribution of ceramides metabolism in psychiatric disorders;Journal of Neurochemistry;2023-02-17

3. Psychological distress and metabolomic markers: A systematic review of posttraumatic stress disorder, anxiety, and subclinical distress;Neuroscience & Biobehavioral Reviews;2022-12

4. Acid Sphingomyelinase Is a Modulator of Contextual Fear;International Journal of Molecular Sciences;2022-03-21

5. Psychological Distress and Metabolomic Markers: A Systematic Review;2022-02-25